Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 11, 2014, Pages 7093-7103

  de Sisternes, Luis ^a   Simon, Noah ^b,c   Tibshirani, Robert ^b   Leng, Theodore ^a   Rubin, Daniel L ^a,b,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; Optical coherence tomography; Prediction; Risk assessment; Statistical modeling

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COMPUTER PREDICTION; DECISION MAKING; DIAGNOSTIC ACCURACY; DISEASE COURSE; DRUSEN; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; RETINA DETACHMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCAR FORMATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STATISTICAL MODEL; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; MACULAR DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PIGMENT EPITHELIUM; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RETINA MACULA LUTEA; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; REPRODUCIBILITY OF RESULTS; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; ROC CURVE; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84910029571     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14918     Document Type: Article

References (42)

1. Klein R, Klein B, Jensen S, Meuer S. The five-year incidence and progression of age-related maculopathy: the beaver dam eye study. Ophthalmology. 1997;104:7-21.
2. Wong RW, Richa DC, Hahn P, et al. Iron toxicity as a potential factor in AMD. Retina. 2007;27:997-1003.
3. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: Pathogenesis, Natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44:1-29.
4. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c, and e, beta carotone, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Opththalmol. 2001;119:1417-1436.
5. Age-Related Eye Disease Study Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574.
6. Friberg TR, Bilonick RA, Brennen PM. Analysis of the relationship between drusen size and drusen area in eyes with age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2011;42:369-375.
7. Feigl B, Morris CP. The challenge of predicting macular degeneration. Curr Med Res Opin. 2011;27:1745-1748.
8. Smith RT, Sohrab MA, Pumariega NM, et al. Drusen analysis in a human-machine synergistic framework. Arch Ophthalmol. 2011;129:40-47.
9. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/ CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102:7227-7232.
10. Hughes AE, Orr N, Esfandiary H, et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006;38:1173-1177.
11. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297:1793-1800.
12. Hageman GS, Gehrs K, Lejnine S, et al. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genom. 2011;5:420-440.
13. Yu Y, Reynolds R, Rosner B, et al. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53: 1548-1556.
14. Seddon JM, Reynolds R, Maller J, et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044- 2053.
15. Seddon JM, Reynolds R, Yu Y, Rosner B. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol. 2013;131:448- 455.
16. Perlee LT, Bansal AT, Gehrs K, et al. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology. 2013;120:1880-1892.
17. Friberg TR, Bilonick RA, Brennen P. Is drusen area really so important? an assessment of risk of conversion to neovascular AMD based on computerized measurements of drusen. Invest Ophthalmol Vis Sci. 2012;53:1742-1751.
18. Buitendijk GHS, Rochtchina E, Myers C, et al. Prediction of age-related macular degeneration in the general population: The three continent AMD consortium. Ophthalmology. 2013; 120:2644-2655.
19. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
20. Zysk AM, Nguyen FT, Oldenburg AL, et al. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Optics. 2007;12:051403.
21. Alexander L, Choate W. Optical coherence tomography: rewriting the standard of care in diagnosis, management and interventional assessment. Rev Optometry. 2004;141:1CE- 8CE.
22. De Niro JE, McDonald HR, Johnson RN, et al. Sensitivity of fluid detection in patients with neovascular AMD using spectral domain optical coherence tomography high-definition line scans. Retina. 2014;34:1163-1166.
23. Shuang L, Wang B, Yin B, et al. Retinal nerve fiber layer reflectance for early glaucoma diagnosis. J Glaucoma. 2014; 23:e45-e52.
24. Akashi A, Kanamori A, Nakamura M, et al. The ability of macular parameters and circumpapillary retinal nerve fiber layer by three SD-OCT instruments to diagnose highly myopic glaucoma. Invest Ophthalmol Vis Sci. 2013;54:6025-6032.
25. Talu SD. Optical coherence tomography in the diagnosis and monitoring of retinal diseases. ISRN Biomed Img. 2013;2013: 1-13.
26. Jain N, Farsiu S, Khanifar AA, et al. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci. 2010; 51:4875-4883.
27. Schuman SG, Koreishi AF, Farsiu S, et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009;116:488-496.
28. Farsiu S, Chiu SJ, O'Connell RV, et al. Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology. 2014;121:162-172.
29. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883-1890.
30. Yi K, Mujat M, Park BH, Sun W, et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular agerelated macular degeneration. Br J Ophthalmol. 2009;93:176- 181.
31. Chiu SJ, Izatt JA, O'Connell RV, et al. Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. Invest Ophthalmol Vis Sci. 2012;53:53-61.
32. Chen Q, Leng T, Zheng L, et al. Automated drusen segmentation and quantification in SD-OCT images. Med Image Anal. 2013;17:1058-1072.
33. Chen Q, Leng T, Zheng L, et al. An improved optical coherence tomography-derived fundus projection image for drusen visualization. Retina. 2014;34:996-1005.
34. Rubin DL, de Sisternes L, Kutzscher L, et al. Quantitative evaluation of drusen on photographs. Ophthalmology. 2013; 120:644-644.e2.
35. Nelder JA, Wedderburn RWM. Generalized linear models. J Roy Stat Soc A (General). 1972;135:370-384.
36. Cox DR. Regression models and life tables (with discussion). J Roy Stat Soc B. 1972;34:187-220.
37. Tibshirani R. Regression shrinkage and selection via the Lasso. J Roy Stat Soc B. 1996;58:267-288.
38. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958;53:457-481.
39. Fitzmaurice GM, Laird NM, James H, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons, Inc.; 2004:326-328.
40. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc. 2002;64:479-498.
41. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440-9445.
42. Efron B. Bootstrap methods: another look at the jackknife. Ann Statist. 1979;7:1-26.